Browse Acute myelocytic leukemia topic

Subtopics (13)

Articles

1-35 out of 35 article(s)

Title	Author	Type	Date	Words
CytRx Announces Positive Phase 2 Results For Tamibarotene in the Treatment of Relapsed Acute Promyelocytic Leukemia.		Financial report	Dec 7, 2009	1396
CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia.			Sep 14, 2009	1207
CytRx Reports Favorable Progress Update for Its Pivotal Phase 2 Clinical Trial with Tamibarotene as a Third-line Treatment for Acute Promyelocytic Leukemia.			Jun 29, 2009	1066
Misread marks and cancer.	Saey, Tina Hesman	Brief article	Jun 6, 2009	128
Seattle Genetics Completes Enrollment in Lintuzumab Phase IIb Clinical Trial for Patients with Acute Myeloid Leukemia.			Feb 25, 2009	696
Ambit Biosciences Presents Data on its Targeted Cancer Therapeutic AC220 for Acute Myeloid Leukemia.			Dec 9, 2008	1477
Data Presented at this Year's ASH Meeting Demonstrate Prolonged Overall Survival for Patients with Acute Myeloid Leukemia.			Dec 9, 2008	457
AML patients: New way to gauge treatment response.		Report	Sep 1, 2008	400
Alabama Supreme Court ends toxic-tort catch-22.	Porter, Rebecca		Apr 1, 2008	660
Xenomics Announces License with Warnex of Acute Myeloid Leukemia Assay.			Feb 21, 2008	469
Xanthus' Xanafide Bypasses Multi-Drug Resistance Proteins in Acute Myeloid Leukemia.			Dec 10, 2007	976
Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH.			Dec 10, 2007	1029
Ambit Biosciences Presents Data on AC220 in Acute Myeloid Leukemia at American Society for Hematology Conference.		Conference news	Dec 8, 2007	710
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia.			Nov 9, 2007	767
European Commission Grants Orphan Drug Designation to Xanthus' Xanafide for the Treatment of Acute Myeloid Leukemia.			Oct 26, 2007	708
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia.			Oct 15, 2007	874
Xanthus Initiates Pivotal Phase 3 Trial of Xanafide in Secondary Acute Myeloid Leukemia.			Oct 8, 2007	680
INNOVIVE Pharmaceuticals.		Brief article	Sep 1, 2007	159
An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemia.	Young, A.M.; Powles, T.; Holmes, P.; Wang, J.; Nelson, M.; Anderson, J.; Bower, M.D.; Brock, C.S.	Case study	Sep 1, 2007	2945
INNOVIVE Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Phase II Clinical Trial with Tamibarotene in Refractory Acute Promyelocytic Leukemia.			Aug 3, 2007	1167
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia.			Jul 11, 2007	1129
Xanthus Completes Special Protocol Assessment with FDA for Phase 3 Registration Trial of Xanafide in Patients with Secondary Acute Myeloid Leukemia.		Clinical report	Jun 12, 2007	678
INNOVIVE Pharmaceuticals Receives FDA Fast Track Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia.			Jun 7, 2007	948
Human interaction is key to effective patient education.	Wujcik, Debra	Editorial	May 1, 2007	427
Myeloid sarcoma.	Thompson, Lester D.R.		Aug 1, 2005	498
Novel drug fights leukemia leukemia.		Brief Article	Jan 10, 2004	204
Leukemia treatments nearing prime time. (Smart Drugs).	Seppa, N.	Brief Article	Jun 15, 2002	624
Risk factors for acute myeloid leukemia and multiple myeloma: a combination of GIS and case-control studies. (Features).	Anton-Culver, Hoda	Statistical Data Included	Mar 1, 2002	5981
c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.	Chen, Jian; Yanuck, Rudolph R., III; Abbondanzo, Susan L.; Chu, Wei-Sing; Aguilera, Nadine S.I.		Nov 1, 2001	2886
Cauda equina syndrome in a 65-year-old man, status post-bone marrow transplant for chronic myeloid leukemia. (Pathologic Quiz Case).	Dalton, Scott R.; Ririe, David W.; Neuhauser, Thomas S.		Oct 1, 2001	1097
Head and neck granulocytic sarcoma with acute myeloid leukemia: Three rare cases.	Dilek, Imdat		Apr 1, 2001	2079
Genetic defect needs aggressive treatment.		Brief Article	Oct 1, 1998	382
Arsenic: a novel cancer remedy?	Fackelmann, Kathleen	Brief Article	Apr 11, 1998	168
Better leukemia survival.	Raloff, Janet	Brief Article	Oct 8, 1994	341
New treatment shuts off oncogene.		Brief Article	Jun 6, 1992	264